In the face of skyrocketing costs, tariff turmoil, and pricing pressure, leading life sciences companies are turning to a new kind of intelligence—one that doesn’t just inform decisions, but takes them
LONDON, UK — As inflation squeezes margins and global health systems demand more for less, a growing number of MedTech and Pharma leaders have quietly ...
Satisfied Users & 
Approved Press Releases
